|
Sebia Inc
flc® elisa assay Flc® Elisa Assay, supplied by Sebia Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sebia+flc+elisa+assay/flc+lambda+elisa+kit/pm33593038-1322-12-11 Average 90 stars, based on 1 article reviews
flc® elisa assay - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Sebia Inc
sebia flc elisa ![]() Sebia Flc Elisa, supplied by Sebia Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sebia+flc+elisa+assay/sebia+flc+elisa/pmc09421952-175-0-0 Average 90 stars, based on 1 article reviews
sebia flc elisa - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Sebia Inc
sebia flc elisa kappa lambda ![]() Sebia Flc Elisa Kappa Lambda, supplied by Sebia Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sebia+flc+elisa+assay/assay+elisa+flc+sebia/pmc12524387-4-0-0 Average 86 stars, based on 1 article reviews
sebia flc elisa kappa lambda - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
Sebia Inc
kappa flc assay ![]() Kappa Flc Assay, supplied by Sebia Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sebia+flc+elisa+assay/elisa+assay+for+kappa+and+lambda+flc+measurement/pm30243748-84-12-21 Average 90 stars, based on 1 article reviews
kappa flc assay - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Sebia Inc
automated solid phase sandwich enzyme-linked immunosorbent assay (elisa) flc approach ![]() Automated Solid Phase Sandwich Enzyme Linked Immunosorbent Assay (Elisa) Flc Approach, supplied by Sebia Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sebia+flc+elisa+assay/automated+solid+phase+sandwich+enzyme+linked+immunosorbent+assay++elisa++flc+approach/pm33991536-71-8-0 Average 90 stars, based on 1 article reviews
automated solid phase sandwich enzyme-linked immunosorbent assay (elisa) flc approach - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: EJHaem
Article Title: Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis
doi: 10.1002/jha2.516
Figure Lengend Snippet: Reference values for free light chain (FLC) quantification tests provided by the manufacturers
Article Snippet:
Techniques: Enzyme-linked Immunosorbent Assay
Journal: EJHaem
Article Title: Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis
doi: 10.1002/jha2.516
Figure Lengend Snippet: Raw free light chain (FLC) data and dFLC values of the whole cohort . ( A ) Linear regression analyses of FLC κ (left) and λ (right) values obtained by ELISA and N‐Latex presented on a Log scale. Points represent patients with AL amyloidosis (green, κ AL; light blue, λ AL), and grey triangles represent controls. Grey lines represent perfect agreement. Passing‐Bablok slope coefficient and intercept with 95% CI, Pearson r for linear fitting with 95% CI and p value, were calculated for all values and iFLC only. ( B ) Bland‐Altman plots of the agreement between N‐Latex and ELISA values for κ (left) and λ (right) FLC. The x‐axis displays the mean of Log‐transformed FLC values obtained by ELISA and N‐Latex ([LogFLC ELISA + LogFLC N‐Latex]/2); the y‐axis displays the difference (LogFLC ELISA ‐ LogFLC N‐Latex). The horizontal plain line shows the mean of the differences, and the dotted horizontal lines show the 95% CI (with back transformation of the Log values). ( C and D ) The dFLC were calculated for the 96 AL patients ( C ) and the 48 controls ( D ) using κ and λ FLC values measured with ELISA (red x) and N‐Latex (blue dots). Results were also obtained from Freelite quantification in 25 patients with AL amyloidosis (orange dots). The vertical dotted line in A separates patients with κ ( n = 18) and λ ( n = 78) AL amyloidosis. Numbers on the x‐axis corresponds to individual patients. The patients were ordered according to dFLC ELISA value (from largest to smallest). Framed numbers refer to patients’ serums displaying a peak on sEP (0.1 to 0.4 g/L, tangential skim) corresponding to the mFLC. ( E ) Receiver operating characteristic (ROC) analysis of ELISA dFLC values from the 144 patients. The area under the curve (AUC), p value, and results for a selected cut‐off point with 95% CI are reported
Article Snippet:
Techniques: Enzyme-linked Immunosorbent Assay, Transformation Assay
Journal: EJHaem
Article Title: Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis
doi: 10.1002/jha2.516
Figure Lengend Snippet: Concordance analysis and diagnostic performance . ( A ) Free light chain (FLC) concentrations measured by N‐Latex and ELISA in patients with AL amyloidosis (green, κ AL; light blue, λ AL) and in control patients (grey triangles). The grey lines delimit lower and upper reference values for FLC concentration and κ/λ ratio; points in the light grey area have normal FLC concentrations and κ/λ ratio. ( B and C ) Clinical concordance analysis of the κ/λ ratio between ELISA and N‐Latex within the AL cohort (B) and the control cohort ( C ). In B, green and blue frames delimit results for κ and λ AL amyloidosis, respectively. ( D ) Receiver operating characteristic (ROC) curve analysis of ELISA κ/λ ratio values from λ AL and control patients. The AUC, p value, and results for four selected cut‐offs points with 95% CI are reported
Article Snippet:
Techniques: Diagnostic Assay, Enzyme-linked Immunosorbent Assay, Control, Concentration Assay
Journal: EJHaem
Article Title: Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis
doi: 10.1002/jha2.516
Figure Lengend Snippet: Diagnosis performance
Article Snippet:
Techniques: Biomarker Discovery, Enzyme-linked Immunosorbent Assay
Journal: EJHaem
Article Title: Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis
doi: 10.1002/jha2.516
Figure Lengend Snippet: Coherence of ELISA and N‐Latex results during monitoring of AL amyloidosis patients . The follow‐up under treatment of five AL amyloidosis patients using dFLC values calculated using N‐Latex and ELISA is shown. The first time point corresponds to diagnosis. Monoclonal components detected on sIFE are indicated for each patient. All patients, except #56, initially had a peak of entire IgG or IgA on serum electrophoresis. Triangles represent ELISA and squares, N‐Latex, with filled and open symbols referring to normal and abnormal κ/λ ratios, respectively. The black arrow indicates the time of first negative sIFE (disappearance of monoclonal component(s) detected at diagnosis). The hematologic response at the last time point is indicated (blue, N‐Latex; red, ELISA). CR, complete remission (negative sIFE and uIFE, normal FLC level and κ/λ ratio); NR, no response; VGPR, very good partial response (dFLC reduction > 50%)
Article Snippet:
Techniques: Enzyme-linked Immunosorbent Assay, Biomarker Discovery, Electrophoresis
Journal: EJHaem
Article Title: Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis
doi: 10.1002/jha2.516
Figure Lengend Snippet: Comparative analysis using Freelite, N‐Latex, and ELISA in a sub‐cohort of AL patients including difficult cases . ( A ) The dFLCs were calculated for 25 patient samples analyzed with each FLC test. Yellow circles, blue squares, and red x represent values obtained with Freelite, N‐Latex, and ELISA, respectively. A black line links results from the same patient. ( B ) FLC results, presence of an mFLC on sIFE, proteinuria, and eGFR (MDRD equation) in seven patients—all with λ AL amyloidosis—that were misdiagnosed by more than one FLC test. Green and red background indicate values below and above reference range, respectively
Article Snippet:
Techniques: Enzyme-linked Immunosorbent Assay
Journal: International Journal of Molecular Sciences
Article Title: Serum and Tissue Light-Chains as Disease Biomarkers in AL Amyloidosis
doi: 10.3390/ijms26199511
Figure Lengend Snippet: Mechanisms of damage for free light chains. On the left, the direct cytotoxic effect of light chains on cells; on the right, the mass effect of amyloid deposition on tissue. In the myocardial cell on the left box, there is a brief representation of the molecular cascade of the direct damage .
Article Snippet:
Techniques:
Journal: International Journal of Molecular Sciences
Article Title: Serum and Tissue Light-Chains as Disease Biomarkers in AL Amyloidosis
doi: 10.3390/ijms26199511
Figure Lengend Snippet: Normal range of kappa/lambda FLC ratio Freelite ® assay. The serum quantification of free light chains (FLCs) and the kappa/lambda ratio vary according to renal function. ( a ) A normal kappa/lambda ratio in case of normal renal function (0.26–1.65) has a 100% negative predictive value for light-chain cardiac amyloidosis (AL-CA). If a kidney disease is present, the normal range is 0.37–3.10. ( b ) Comparison of two widely used serum free light chain (sFLC) assays. Freelite ® (The Binding Site, Birmingham, UK) uses polyclonal antibodies and is available on multiple clinical chemistry analyzers. N Latex FLC (Siemens Healthineers, Erlangen, Germany) employs a monoclonal antibody mixture and is available exclusively on Siemens nephelometric platforms.
Article Snippet:
Techniques: Comparison, Binding Assay